OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang is currently in discussions to secure funding for a new artificial intelligence startup focused on drug discovery. The venture is reportedly seeking a valuation of $2 billion, highlighting growing investor interest in applying large-scale machine learning models to the pharmaceutical and life sciences sectors.